Contact Us
INNOGLY INNOGLY INNOGLY INNOGLY
Navigation
  • About us
    • COST Action
    • Network members
    • Scientific Outputs
      • Scientific Publications
      • Abstracts from Events
  • News
  • Events
  • Working Groups
    • Development and Cancer
    • Autophagy
    • Immunity
    • GAGs
  • STSM
    • STSM information
    • STSM proposal
    • STSM evaluation
    • Awarded STSMs
  • ITC Grants
  • Training Schools

Logged out

Lost Password?

News

Training School on the Conjugation of Glycans onto Nanomaterials
The COST action "INNOGLY" (Innovation with glycans: new frontiers from ...
Read More
Glycosaminoglycan Interaction Networks and Databases
The article GLYCOSAMINOGLYCAN INTERACTION NETWORKS AND DATABASES , by Sylvie Ricard Blum and ...
Read More
INNOGLY Annual Meeting 2022 (4-6 May Lugano)
4-6 May 2022, Lugano, Switzerland The Annual Meeting of the INNOGLY ...
Read More
Exploring the Multifaceted Roles of Glycosaminoglycans (GAGs): Special Issue Reprint
Read More
GlycosAminoGlycans: What remains to be solved?
  Scientific and Organizing Committee: Dragana Nikitovic & Serge Perez Topical organizing ...
Read More

Research Topic: Frontiers in Immunology

Urinary tract infections (UTIs) are among the most common bacterial infections in humans worldwide. From 1990 to 2017 incident and death rates were observed to have increased by 52 % and 149 %, respectively. UTIs may lead to pyelonephritis and sepsis, which can result in fatal outcomes. One of the unresolved problems with UTIs are recurrent infections and pathogen multidrug resistance.

Gram-negative bacteria such as E. coli and P. mirabilis are the dominant cultivable pathogenic bacteria of UTIs. Multiple bacterial virulence factors – such as adhesins, exo-enzymes, biofilm formation, and pro-inflammatory activities (endotoxins) – are involved in catheter colonization, ascending infection, inflammation, and renal stone formation often associated with UTIs.

Recent advances in whole genomes sequencing (WGS), transcriptomes, and metabolomics are paving the way to more complete pictures of the human urinary tract microbiome and its role in UTIs. However, UTIs still remain complex biological phenomena that involve an interplay between hosts, pathogens, and environmental factors. As a result, multidisciplinary approaches are needed to advance our knowledge in the field of UTIs and to develop impactful novel treatment options.

In this Research Topic we aim to capture the latest developments in the pathogenesis of UTIs, as well as the molecular basis for adhesion and biofilm formation in UTIs. We welcome submissions on, but not limited to, the following sub themes:

• Urinary tract and gut microbiome analysis and its role in UTI pathogenesis.
• Elucidation of clonal P. mirabilis and E. coli differentiation during the course of UTIs, a phenomenon correlated with multidrug resistance in UTIs.
• Studies on the transition of planktonic bacterial to sessile cells and mono- and poly-species bacterial biofilms formation in UTIs.
• The molecular basis for adhesion and biofilm formation in UTIs.
• Novel nano- and biomaterials for catheter assembly with anti-bacterial features, for UTI prevention.

 

Keywords: Urinary Tract Infection, UTIs, Catheters, Biofilms, Bacterial Pathogenesis

 

Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

 

https://www.frontiersin.org/research-topics/20575/urinary-tract-infections-molecular-mechanisms-of-pathogenesis

March 25, 2021

Events

Training School on the Conjugation of Glycans onto Nanomaterials
The COST action "INNOGLY" (Innovation with glycans: new frontiers from ...
Read More
WORKSHOP “Neuroglycoproteins in Health and Disease” 24-25 March 2022 Alicante (Spain)
Read More
INNOGLY Annual Meeting 2022 (4-6 May Lugano)
4-6 May 2022, Lugano, Switzerland The Annual Meeting of the INNOGLY ...
Read More

Follow us on Twitter


Follow INNOGLY

Twitter Timeline

RT @derda_lab: Checkout our #MachineLearning paper based on #NeuralNetworks that can predict protein-glycan interactions now out on @Chemic…

RT @bmmc_9: We are pleased to announce that Prof. Roberto Adamo will give a talk on Microbial Glycans in Vaccines. Follow him. Don’t miss t…

RT @ACSCentSci: #ICYMI #glycotime

Research by Jerry Turnbull & team @CarboKeele @LivUni

Synthetic Heparan Sulfate Mimetic Pixatimod (PG54…

RT @CarolynBertozzi: @AsAshraf123321 And in the clinic! Check out E-602 from @Palleon_Pharma

https://t.co/95PPcHwpSD

RT @RobertoAdamo10: Finally out this exciting review in collaboration with Prof. Codèe on synthetic glycans to improve glycoconjugate vacci…

POLICY STATEMENT:

Biomedicine and Molecular Biosciences Action CA18103 is funded by COST, which is supported by the EU Framework Programme Horizon 2020.

COST Action CA18103

© Copyright 2022. All Rights Reserved | Powered by innogly.eu | Designed by AWA
  • Imprint
  • /
  • Privacy policy
  • /
  • Cookie Policy (EU)
  • /
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
Preferences
{title} {title} {title}